About this episode
The episode features a discussion with Jonathan Graham about in-house legal leadership in biotech companies and the influence of science, intellectual property, and regulation on strategy.
John is joined by Jonathan Graham, Executive Vice President and General Counsel and Secretary of Amgen, one of the world’s largest biotech companies and one of the pioneers of the industry. They discuss in-house legal leadership in major biotech companies and how science, intellectual property, and regulation shape strategy. Jonathan began his practice clerking for the Ninth Circuit Court of Appeals, then became a litigator for a large firm. Later, his career shifted in-house. He believes tha...
People in this episode
Host: John
Guest: Jonathan Graham
Topics covered
- biotech
- in-house legal leadership
- intellectual property
- regulation
- strategy
Keywords
- biotech
- legal leadership
- intellectual property
- regulation
- Amgen
Mentioned in this episode
Organizations: Amgen, Ninth Circuit Court of Appeals, large firm
More episodes of Law, disrupted
- Wildfire Litigation · June 12, 2026 · 41 min
- Inside QE’s Remarkable UK Class Action Trial Win for Qualcomm · June 4, 2026 · 26 min
- The Antitrust Lawyer Who Parachuted Into Trial and Beat Live Nation and Ticketmaster for 33 States · May 28, 2026 · 33 min
- Re-release: Renowned Criminal Defense Lawyer Ben Brafman on Trial Practice · May 22, 2026 · 43 min
- Inside QE'S $440 Million Win Against Credit Suisse For SoftBank · May 15, 2026 · 34 min
- Re-release: The Evolution of Legal Assets as an Investment Class · May 7, 2026 · 42 min
Explore listener stats, chart rankings, contacts and more on the Law, disrupted podcast page.